Arcellx Inc (ACLX)
53.68
+0.88
(+1.68%)
USD |
NASDAQ |
May 17, 16:00
53.68
0.00 (0.00%)
After-Hours: 16:58
Arcellx Profit Margin (Quarterly): -18.34% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -18.34% |
December 31, 2023 | 31.42% |
September 30, 2023 | -263.0% |
Date | Value |
---|---|
June 30, 2023 | -166.8% |
March 31, 2023 | -152.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-263.0%
Minimum
Sep 2023
31.42%
Maximum
Dec 2023
-113.9%
Average
-152.7%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
Gilead Sciences Inc | -62.37% |
Eli Lilly and Co | 25.58% |
Viking Therapeutics Inc | -- |
Blueprint Medicines Corp | 92.74% |
NovaBay Pharmaceuticals Inc | -122.2% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -13.69% |
Return on Assets | -7.29% |
Return on Invested Capital | -13.69% |
Operating Margin (Quarterly) | -40.27% |
Return on Net Operating Assets | -58.94% |